A Combination of UTMD-Mediated HIF-1<i>α</i> shRNA Transfection and TAE in the Treatment of Hepatic Cancer

<div>The survival curve of hepatic cancer rats in four groups.</div>

BioMed Research International

Figure 1: A Combination of UTMD-Mediated HIF-1<i>α</i> shRNA Transfection and TAE in the Treatment of Hepatic Cancer 